Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meta-analytical studies on new antidepressants.

I M Anderson1

  • 1Neuroscience and Psychiatry Unit, School of Psychiatry and Behavioural Sciences, University of Manchester, UK.

British Medical Bulletin
|November 27, 2001
PubMed
Summary

Most antidepressants show similar efficacy, but serotonin and noradrenaline re-uptake inhibitors (SNRIs) are more effective than selective serotonin re-uptake inhibitors (SSRIs). Newer antidepressants generally offer better tolerability than older ones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression.

Molecular psychiatry·2017
Same author

Association of ATP6V1B2 rs1106634 with lifetime risk of depression and hippocampal neurocognitive deficits: possible novel mechanisms in the etiopathology of depression.

Translational psychiatry·2016
Same author

Variants in the CNR1 gene predispose to headache with nausea in the presence of life stress.

Genes, brain, and behavior·2016
Same author

Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms.

Translational psychiatry·2016
Same author

Distinct effects of folate pathway genes MTHFR and MTHFD1L on ruminative response style: a potential risk mechanism for depression.

Translational psychiatry·2016
Same author

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.

Journal of psychopharmacology (Oxford, England)·2015

Area of Science:

  • Psychiatry and Pharmacology
  • Evidence-Based Medicine

Background:

  • Antidepressant use for depressive disorders is widespread.
  • Numerous meta-analyses exist, necessitating a synthesis of their findings.

Purpose of the Study:

  • To systematically review meta-analyses comparing the efficacy and tolerability of newer antidepressants against older ones.
  • To provide evidence-based guidance on antidepressant selection.

Main Methods:

  • Systematic search of meta-analyses on antidepressant use in depressive disorders.
  • Selection of 18 meta-analyses focusing on comparative randomized controlled trials (RCTs) of newer antidepressants.
  • Analysis of efficacy and tolerability data.

Main Results:

  • Little difference in efficacy between most new and old antidepressants.
  • Superior efficacy of serotonin and noradrenaline re-uptake inhibitors (SNRIs) over selective serotonin re-uptake inhibitors (SSRIs).
  • SSRIs generally show better tolerability than tricyclic antidepressants (TCAs), though fluvoxamine may have poorer tolerability.
  • No increased risk of suicidal acts with fluoxetine in low-risk patients.

Conclusions:

  • While many antidepressants have similar efficacy, SNRIs may be preferred over SSRIs.
  • SSRIs offer better general tolerability compared to TCAs.
  • The quality of meta-analyses and included studies is variable, requiring cautious interpretation for clinical practice.

Related Experiment Videos